Your browser doesn't support javascript.
loading
Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Lee, Joo Ho; Lee, Jeong Eun; Kahng, Jee Ye; Kim, Se Hoon; Park, Jun Sung; Yoon, Seon Jin; Um, Ji-Yong; Kim, Woo Kyeong; Lee, June-Koo; Park, Junseong; Kim, Eui Hyun; Lee, Ji-Hyun; Lee, Joon-Hyuk; Chung, Won-Suk; Ju, Young Seok; Park, Sung-Hong; Chang, Jong Hee; Kang, Seok-Gu; Lee, Jeong Ho.
Afiliación
  • Lee JH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Lee JE; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Kahng JY; Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, South Korea.
  • Kim SH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Park JS; Department of Biological Sciences, KAIST, Daejeon, South Korea.
  • Yoon SJ; Department of Pathology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Um JY; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Kim WK; Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee JK; Department of Bio and Brain Engineering, KAIST, Daejeon, South Korea.
  • Park J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Kim EH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Lee JH; Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee JH; Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Chung WS; Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Ju YS; Department of Biological Sciences, KAIST, Daejeon, South Korea.
  • Park SH; Department of Biological Sciences, KAIST, Daejeon, South Korea.
  • Chang JH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Kang SG; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
  • Lee JH; Department of Bio and Brain Engineering, KAIST, Daejeon, South Korea.
Nature ; 560(7717): 243-247, 2018 08.
Article en En | MEDLINE | ID: mdl-30069053
ABSTRACT
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall survival of fifteen months1,2. Identifying the cell of origin that harbours mutations that drive GBM could provide a fundamental basis for understanding disease progression and developing new treatments. Given that the accumulation of somatic mutations has been implicated in gliomagenesis, studies have suggested that neural stem cells (NSCs), with their self-renewal and proliferative capacities, in the subventricular zone (SVZ) of the adult human brain may be the cells from which GBM originates3-5. However, there is a lack of direct genetic evidence from human patients with GBM4,6-10. Here we describe direct molecular genetic evidence from patient brain tissue and genome-edited mouse models that show astrocyte-like NSCs in the SVZ to be the cell of origin that contains the driver mutations of human GBM. First, we performed deep sequencing of triple-matched tissues, consisting of (i) normal SVZ tissue away from the tumour mass, (ii) tumour tissue, and (iii) normal cortical tissue (or blood), from 28 patients with isocitrate dehydrogenase (IDH) wild-type GBM or other types of brain tumour. We found that normal SVZ tissue away from the tumour in 56.3% of patients with wild-type IDH GBM contained low-level GBM driver mutations (down to approximately 1% of the mutational burden) that were observed at high levels in their matching tumours. Moreover, by single-cell sequencing and laser microdissection analysis of patient brain tissue and genome editing of a mouse model, we found that astrocyte-like NSCs that carry driver mutations migrate from the SVZ and lead to the development of high-grade malignant gliomas in distant brain regions. Together, our results show that NSCs in human SVZ tissue are the cells of origin that contain the driver mutations of GBM.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Ventrículos Laterales / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Ventrículos Laterales / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur
...